IL33 and neoplasm: It is important to highlight that the co-culture with organoids might represent a model for early-stage tumors, so we hypothesize that the TME could exert different effects on MCs depending on the tumor stage, and on the activating (e.g. IL-33) and inhibiting (e.g. lactate) tumor-derived molecules that can shape MC metabolism and functions.